Olema Pharmaceuticals, Inc. (OLMA) Cash Flow Statement
Olema Pharmaceuticals, Inc. (OLMA) generated -$164.7M of operating cash flow over the twelve months to 2026-06-30, spent $221000 on capital expenditure and had free cash flow of -$165.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OLMAOlema Pharmaceuticals, Inc.Follow OLMA — free
—
Price chart with a free account
- Market cap
- 560.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -50.7 | -82.1 | -83.7 | -104.4 | -146.7 | -164.7 | |
| Capital expenditure | 1.6 | 0.4 | — | 0.2 | 0.0 | -0.2 | |
| Free cash flow | -52.3 | -82.4 | — | -104.5 | -146.7 | -165.0 | |
| Stock-based compensation | 15.9 | 18.8 | 17.3 | 22.6 | 17.6 | — |
USD millions · SEC XBRL
Olema Pharmaceuticals, Inc. — questions
- What is Olema Pharmaceuticals, Inc.'s operating cash flow?
- -$164.7M over the twelve months to 2026-06-30.
- How much does Olema Pharmaceuticals, Inc. spend on capital expenditure?
- $221000 over the twelve months to 2026-06-30.
- What is Olema Pharmaceuticals, Inc.'s free cash flow?
- -$165.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Olema Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.